Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
cyproterone acetate
Alphapharm Pty Ltd
Registered
CYPRONE _cyproterone acetate_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Cyprone. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Cyprone against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT CYPRONE IS USED FOR Cyprone is an anti-androgen medicine. Androgens such as testosterone are natural male sex hormones which are also produced, to a slight extent, in females. MEN: In men, androgens may help cancer cells to grow in some types of prostate cancer. By blocking these hormones, Cyprone may slow or stop the growth of cancer. Cyprone may also be used in combination with other medicines or following surgical removal of the testes to treat side effects such as "hot flushes" or "sweats" and to prevent any initial worsening of the disease. Cyprone is also used to reduce abnormal sex drive in men. WOMEN: In women, androgens may increase hair growth, loss of scalp hair and secretion of oil from the sweat glands. By blocking these hormones, Cyprone may slow or stop excessive hairiness, loss of scalp hair, acne, oily skin and dandruff. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is available only with a doctor's prescription. BEFORE YOU TAKE CYPRONE _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE CYPRONE IF YOU HAVE AN ALLERGY TO: • cyproterone acetate, the active ingredient in Cyprone • any of the ingredients listed at the end of this leaflet Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, Read the complete document
CYPRONE _Cyproterone Acetate _ PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient : cyproterone acetate Chemical name : 6-chloro-17α-hydroxy-1α,2α-methylene-pregna-4,6-diene-3,20-dione acetate Structural formula : Molecular formula : C 24 H 29 ClO 4 Molecular weight : 416.94 CAS Registry no. : 427-51-0 DESCRIPTION Cyproterone acetate is a white to pale yellow, odourless crystalline powder. M.P. 206-213°C. Cyproterone acetate is very soluble in chloroform and dioxane, freely soluble in acetone and benzene, soluble in ethanol, methanol and ethyl acetate, sparingly soluble in solvent hexane, and almost insoluble in water. Each Cyprone tablet contains 50 mg of cyproterone acetate. The tablets also contain the following inactive excipients: lactose, maize starch, povidone, colloidal anhydrous silica and magnesium stearate. The tablets are gluten free. PHARMACOLOGY Cyprone is an antiandrogenic hormone preparation. Cyproterone acetate inhibits competitively the effect of androgens at androgen-dependent target organs, e.g. it shields the prostate from the effect of androgens originating from the gonads and/or the adrenal cortex. Prostatic carcinoma and its metastases are in general androgen-dependent, Androcur therefore exerts a direct antiandrogenic action on the tumour and its metastases. Cyproterone acetate in addition has a progestogenic action exerting a negative feedback effect centrally on the hypothalamic receptors, so leading to a reduction in gonadotropin release, and hence to diminished production of testicular androgens. Treatment with cyproterone acetate in men results in a reduction of sexual drive and potency and inhibition of gonadal function. These changes are reversible following discontinuation of the therapy. CYPRONE – Product Information 2 The antigonadotropic effect of cyproterone acetate is also exerted when the substance is combined with LHRH agonists. The initial increase of testosterone provoked by this substance group is decreased by cyproterone acetate. In women, hirsutism is dim Read the complete document